Abstract Background Atypical pituitary adenoma has a high rate of recurrence and most of them need further treatment after surgery. This is why early detection is very important. Methods In this study we examined the incidence and outcome of large atypical pituitary adenoma in our patient cohort. The study was a retrospective review of fifty consecutive patients at Assiut university hospital. They all had a large adenoma with supracellar and parasellar extension. They were considered unsuitable for transphenoidal approach. They all had craniotomy. This study was carried out during a thirty eight month period. Pathology reports were reviewed. All patients had MIB-1 immunohistochemical data. Patients with lesions showing excessive MIB-1immuno...
International audiencePrevalence of pituitary incidentaloma is variable: between 1.4% and 27% at aut...
Background: Although pituitary adenomas are considered benign lesions, a small group may exhibit a c...
Pituitary adenomas (PAs) account for up to 15 % of intra-cranial tumors and have a prevalence of 80–...
Abstract Background Pituitary carcinoma is very rare and hard to diagnose. However, some atypical pi...
Introduction: Primary pituitary tumours are classified by the World Health Organization as typical a...
Background and aim: The classification of pituitary adenomas now includes an "atypical" variant, whi...
In 2004, the World Health Organization defined atypical pituitary adenomas as those with a Ki-67 exp...
BACKGROUND: Pituitary adenomas are usually considered benign tumours, although some of them can exh...
Target. Early diagnosis of inactive pituitary adenoma (IPA) is an urgent problem not only in modern ...
Pituitary adenomas are rare in children and adolescents and although mostly benign, they can sometim...
Prevalence: The prevalence of pituitary tumors has been a topic of controversy for many years. Autop...
Introduction The term atypical pituitary adenoma (APA) was revised in the 2004 World Health Organiz...
BACKGROUND: Series of patients systematically investigating the outcome of clinically nonfunctioning...
Background: The WHO has recognized a variant of pituitary adenomas with potential aggressive behavio...
INTRODUCTION: Additional robust criteria to predict early postoperative recurrence of non-functionin...
International audiencePrevalence of pituitary incidentaloma is variable: between 1.4% and 27% at aut...
Background: Although pituitary adenomas are considered benign lesions, a small group may exhibit a c...
Pituitary adenomas (PAs) account for up to 15 % of intra-cranial tumors and have a prevalence of 80–...
Abstract Background Pituitary carcinoma is very rare and hard to diagnose. However, some atypical pi...
Introduction: Primary pituitary tumours are classified by the World Health Organization as typical a...
Background and aim: The classification of pituitary adenomas now includes an "atypical" variant, whi...
In 2004, the World Health Organization defined atypical pituitary adenomas as those with a Ki-67 exp...
BACKGROUND: Pituitary adenomas are usually considered benign tumours, although some of them can exh...
Target. Early diagnosis of inactive pituitary adenoma (IPA) is an urgent problem not only in modern ...
Pituitary adenomas are rare in children and adolescents and although mostly benign, they can sometim...
Prevalence: The prevalence of pituitary tumors has been a topic of controversy for many years. Autop...
Introduction The term atypical pituitary adenoma (APA) was revised in the 2004 World Health Organiz...
BACKGROUND: Series of patients systematically investigating the outcome of clinically nonfunctioning...
Background: The WHO has recognized a variant of pituitary adenomas with potential aggressive behavio...
INTRODUCTION: Additional robust criteria to predict early postoperative recurrence of non-functionin...
International audiencePrevalence of pituitary incidentaloma is variable: between 1.4% and 27% at aut...
Background: Although pituitary adenomas are considered benign lesions, a small group may exhibit a c...
Pituitary adenomas (PAs) account for up to 15 % of intra-cranial tumors and have a prevalence of 80–...